SCHEMBL22014073

SCHEMBL22014073

Cn1c(C(C)(C)SS)nc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.51
ALOX15 P16050 1/20 0.50
ATM Q13315 1/20 0.50
METAP2 P50579 1/20 0.44
METAP1 P53582 1/20 0.44
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
POLB P06746 1/20 0.42
ACSS2 Q9NR19 2/20 0.42
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
PKM P14618 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479700 0.80 SMN1; SMN2 (0.58) SMN1; SMN2ALOX15ATMMETAP2METAP1
SCHEMBL7023960 0.78 ALOX15 (0.55) SMN1; SMN2ALOX15ATMMETAP2METAP1
SCHEMBL6493316 0.77 SMN1; SMN2 (0.55) SMN1; SMN2ALOX15ATMMETAP2METAP1
SCHEMBL6479789 0.77 SMN1; SMN2 (0.59) SMN1; SMN2ALOX15ATMMETAP2METAP1
SCHEMBL38664142 0.77 ALOX15 (0.57) SMN1; SMN2ALOX15ATMMETAP2METAP1
SCHEMBL10969560 0.77 SMN1; SMN2 (0.57) SMN1; SMN2ALOX15ATMMETAP2METAP1
SCHEMBL30034162 0.75 SMN1; SMN2 (0.55) SMN1; SMN2ALOX15ATMMAPTTP53
SCHEMBL8799913 0.75 SMN1; SMN2 (0.60) SMN1; SMN2ALOX15ATMMETAP2METAP1
SCHEMBL5851401 0.75 SMN1; SMN2 (0.55) SMN1; SMN2ALOX15ATMMAPTTP53
SCHEMBL20283874 0.75 SMN1; SMN2 (0.52) SMN1; SMN2ALOX15ATMMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662211-B2 Catalysts and methods for polymer synthesis Saurdi Aramco Technologies Company (SA) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662211-B2 Catalysts and methods for polymer synthesis PPOX, COASY, SOD1 SMN1; SMN2 4314/4885ALOX15 293/4885ATM 4485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.